Divergence of Delta and Beta Variants and SARS-CoV-2 Evolved in Advanced HIV Disease into Two Serological Phenotypes
Sandile Cele(Africa Health Research Institute), Mallory Bernstein(Africa Health Research Institute), Wesley C. Van Voorhis(Infectious Disease Research Institute), Willem A. Hanekom(University of Cape Town), Ntombifuthi Mthabela(Ragon Institute of MGH, MIT and Harvard), Tandile Hermanus(National Health Laboratory Service), Penny L. Moore(National Health Laboratory Service), Mahomed‐Yunus S. Moosa(Centre for the AIDS Programme of Research in South Africa), Sasha W. Tilles(University of Washington), James Emmanuel San, Jennifer Giandhari(University of KwaZulu-Natal), Thumbi Ndung’u(Ragon Institute of MGH, MIT and Harvard), Bernadett I. Gosnell(University of KwaZulu-Natal), Jumari Snyman(Africa Health Research Institute), COMMIT-KZN Team, Túlio de Oliveira(University of Washington), Lavanya Singh(University of KwaZulu-Natal), Shi-Hsia Hwa(Africa Health Research Institute), Yashica Ganga(Africa Health Research Institute), Richard Lessells(Centre for the AIDS Programme of Research in South Africa), Salim S. Abdool Karim(MRC Clinical Trials Unit at UCL), Gila Lustig(Centre for the AIDS Programme of Research in South Africa), Karim Khan(Shenzhen University), Farina Karim(Africa Health Research Institute), Eduan Wilkinson(Lymphatic Education & Research Network), Matilda Mazibuko(Africa Health Research Institute), Houriiyah Tegally(Lymphatic Education & Research Network)
Cited by 1
Related Papers
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|623